Inventor
Toshihiko Ohtomo
Inventor
Gotenba, JP
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides32%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
C12NMicroorganisms or enzymes8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
A01KAnimal husbandry3%
PatentTitleYear
10,782,300GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy202010,451,627Method for assaying soluble GPC3 protein20199,644,029'Cancer diagnosis and treatment of cancer using anti-ROBO1 antibody'20179,434,775'Gene overexpressed in cancer'20169,376,475'Gene overexpressed in cancer'20168,940,488'Cancer diagnosis and treatment of cancer using anti-robo 1 antibody'20158,586,039'Degraded TPO agonist antibody'20138,105,799'Methods of screening compounds inhibiting signal transduction through inflammatory cytokines'20128,034,903'Degraded TPO agonist antibody'20117,892,543'Reshaped human anti-HM 1.24 antibody'20117,812,128'Gene overexpressed in cancer'20107,666,610'Expressing transporters on viral envelopes'20107,563,599'Reshaped human antibody to human medulloblastoma cells'20097,338,797'Compositions for isolating a cDNA encoding a membrane-bound protein'20087,067,297'Mannosyltransferase polypeptides and polynucleotides encoding them and methods for making and using them'20066,989,244'Method for screening compounds inhibiting signal transduction through inflammatory cytokines'20066,908,750'Gene encoding HM1.24 antigen protein and promoter thereof'20056,699,974'Reshaped human anti-HM 1.24 antibody'20046,613,546'Gene encoding HM1.24 antigen protein and promoter thereof'20036,610,485'Methods for isolating a cDNA encoding a membrane-bound protein'20036,551,840'Method of screening TGF--inhibiting substances'20036,451,617'Method of screening TGF- inhibitory substances'20026,214,973'Reshaped human antibody to human medulloblastoma cells'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2020Patents assigned to CHUGAI PHARMACEUTICAL CO LTD (20)· patent assignee history
2001–2009Based in Gotenba, JP· patent location history
2003–2011Based in Gotemba-shi, JP· patent location history
2006–2015Based in Shizuoka, JP· patent location history
2010–2016Patents assigned to OHTOMO TOSHIHIKO (6)· patent assignee history
2010–2017Patents assigned to ABURATANI HIROYUKI (5)· patent assignee history
2010–2016Patents assigned to HIPPO YOSHITAKA (4)· patent assignee history
2010–2016Patents assigned to ITO HIROTAKA (4)· patent assignee history
2010–2016Based in Ibaraki, JP· patent location history
2017–2020Based in Tokyo, JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHUGAI PHARMACEUTICAL CO LTD | 20 | 2001–2020 |
| OHTOMO TOSHIHIKOself | 6 | 2010–2016 |
| ABURATANI HIROYUKI | 5 | 2010–2017 |
| HIPPO YOSHITAKA | 4 | 2010–2016 |
| ITO HIROTAKA | 4 | 2010–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Gotenba, JP | 7 | 2001–2009 |
| Shizuoka, JP | 6 | 2006–2015 |
| Gotemba-shi, JP | 4 | 2003–2011 |
| Tokyo, JP | 3 | 2017–2020 |
| Ibaraki, JP | 3 | 2010–2016 |